922
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Current status of transcatheter mitral valve repair therapies – From surgical concepts towards future directions

Pages 367-376 | Received 02 Aug 2016, Accepted 10 Oct 2016, Published online: 06 Nov 2016

References

  • Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–1011.
  • Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451–2496.
  • Nishimura RA, Otto CM, Bonow RO, et al. 2014. AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521–e643.
  • Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358–1365.
  • Mihaljevic T, Lam B-K, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol. 2007;49:2191–2201.
  • Maisano F, Alfieri O, Banai S, et al. The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? Eur Heart J. 2015;36:1651–1659.
  • Vesely MR, Benitez RM, Robinson SW, et al. Surgical and transcatheter mitral valve repair for severe chronic mitral regurgitation: a review of clinical indications and patient assessment. J Am Heart Assoc. 2015;4:e002424.
  • Carpentier A, Adams DH, Filsoufi F. Carpentier's reconstructive valve surgery. Riverport Lane: Saunders; 2010.
  • Verma S, Mesana TG. Mitral-valve repair for mitral-valve prolapse. N Engl J Med. 2009;361:2261–2269.
  • Yun KL, Fann JI, Rayhill SC, et al. Importance of the mitral subvalvular apparatus for left ventricular segmental systolic mechanics. Circulation. 1990;82:IV89–I104.
  • Levine RA, Hagege AA, Judge DP, et al. Mitral valve disease-morphology and mechanisms. Nat Rev Cardiol. 2015;12:689–710.
  • Shuhaiber J, Anderson RJ. Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement. Eur J Cardiothorac Surg. 2007;31:267–275.
  • Enriquez-Sarano M, Avierinos J-F, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352:875–883.
  • Ling LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med. 1996;335:1417–1423.
  • Grigioni F, Enriquez-Sarano M, Ling LH, et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol. 1999;34:2078–2085.
  • Enriquez-Sarano M, Schaff HV, Orszulak TA, et al. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation. 1995;91:1022–1028.
  • Carpentier A. Cardiac valve surgery – the "French correction”. J Thorac Cardiovasc Surg. 1983;86:323–337.
  • O'Gara P, Sugeng L, Lang R, et al. The role of imaging in chronic degenerative mitral regurgitation. JACC Cardiovasc Imaging. 2008;1:221–237.
  • Perier P, Hohenberger W, Lakew F, et al. Toward a new paradigm for the reconstruction of posterior leaflet prolapse: midterm results of the “Respect Rather Than Resect” approach. Ann Thorac Surg. 2008;86:718–725.
  • Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg. 2001;122:674–681.
  • Nielsen SL, Timek TA, Lai DT, et al. Edge-to-edge mitral repair. Circulation. Am Heart Assoc J. 2001;104:I–29–I–35.
  • De Bonis M, Lapenna E, Maisano F, et al. Long-term results (≤18 Years) of the edge-to-edge mitral valve repair without annuloplasty in degenerative mitral regurgitation: implications for the percutaneous approach. Circulation. 2014;130:S19–S24.
  • Gillinov AM, Tantiwongkosri K, Blackstone EH, et al. Is prosthetic anuloplasty necessary for durable mitral valve repair? Ann Thorac Surg. 2009;88:76–82.
  • Flameng W, Herijgers P, Bogaerts K. Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Circulation. 2003;107:1609–1613.
  • David TE, Armstrong S, McCrindle BW, et al. Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Circulation. 2013;127:1485–1492.
  • Gammie JS, O'Brien SM, Griffith BP, et al. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation. 2007;115:881–887.
  • Espiritu D, Onohara D, Kalra K, et al. Transcatheter mitral valve repair therapies: evolution, status and challenges. Ann Biomed Eng 2016.
  • Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395–1406.
  • Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013;62:1052–1061.
  • Nishimura RA, Vahanian A, Eleid MF, et al. Mitral valve disease-current management and future challenges. Lancet. 2016;387:1324–1334.
  • Feldman T, Kar S, Elmariah S, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015;66:2844–2854.
  • Schueler R, Momcilovic D, Weber M, et al. Acute changes of mitral valve geometry during interventional edge-to-edge repair with the MitraClip system are associated with midterm outcomes in patients with functional valve disease: preliminary results from a prospective single-center study. Circ Cardiovasc Interv. 2014;7:390–399.
  • Seeburger J, Rinaldi M, Nielsen SL, et al. Off-pump transapical implantation of artificial neo-chordae to correct mitral regurgitation: the TACT Trial (Transapical Artificial Chordae Tendinae) proof of concept. J Am Coll Cardiol. 2014;63:914.
  • Weber A, Hurni S, Vandenberghe S, et al. Ideal site for ventricular anchoring of artificial chordae in mitral regurgitation. J Thorac Cardiovasc Surg. 2012;143:S78–S81.
  • Jensen H, Jensen MO, Waziri F, et al. Transapical neochord implantation: is tension of artificial chordae tendineae dependent on the insertion site? J Thorac Cardiovasc Surg. 2014;148:138–143.
  • Acker MA, Parides MK, Perrault LP, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370:23–32.
  • Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374:344–353.
  • Smith PK, Puskas JD, Ascheim DD, et al. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371:2178–2188.
  • Bolling SF, Deeb GM, Brunsting LA, et al. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg. 1995;109:676–682.
  • Braun J, van de Veire NR, Klautz RJM, et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg. 2008;85:430–436.
  • Spoor MT, Geltz A, Bolling SF. Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. Circulation. 2006;114:I67–I71.
  • Khamooshian A, Buijsrogge MP, de Heer F, et al. Mitral valve annuloplasty rings: review of literature and comparison of functional outcome and ventricular dimensions. Innovations. 2014;9:399–415.
  • Magne J, Girerd N, Sénéchal M, et al. Mitral repair versus replacement for ischemic mitral regurgitation: comparison of short-term and long-term survival. Circulation. 2009;120:S104–S111.
  • Kron IL, Hung J, Overbey JR, et al. Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2015;149:752–761.e1.
  • Kron IL, Green GR, Cope JT. Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann Thorac Surg. 2002;74:600–601.
  • Nappi F, Lusini M, Spadaccio C, et al. Papillary muscle approximation versus restrictive annuloplasty alone for severe ischemic mitral regurgitation. J Am Coll Cardiol. 2016;67:2334–2346.
  • Messas E, Guerrero JL, Handschumacher MD, et al. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation. 2001;104:1958–1963.
  • Borger MA, Murphy PM, Alam A, et al. Initial results of the chordal-cutting operation for ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2007;133:1483–1492.
  • Auricchio A, Schillinger W, Meyer S, et al. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol. 2011;58:2183–2189.
  • Grayburn PA, Foster E, Sangli C, et al. Relationship between the magnitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after MitraClip therapy. Circulation. 2013;128:1667–1674.
  • Nickenig G, Estevez-Loureiro R, Franzen O, et al. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011–2012 Pilot European Sentinel Registry. J Am Coll Cardiol. 2014;64:875–884.
  • Suerder D, Corti R, Klersy C, et al. TCT-718 percutaneous mitral valve repair in functional mitral regurgitation: preliminary results from the of the Swiss nationwide investigator-initiated prospective MitraClip® registry (MitraSwiss). J Am Coll Cardiol. 2015;66:B293.
  • Van den Branden BJL, Swaans MJ, Post MC, et al. Percutaneous edge-to-edge mitral valve repair in high-surgical-risk patients: do we hit the target? JACC Cardiovasc Interv. 2012;5:105–111.
  • Velazquez EJ, Samad Z, Al-Khalidi HR, et al. The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: a propensity-matched comparison. Am Heart J. 2015;170:1050–1053.
  • Schofer J, Siminiak T, Haude M, et al. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation. 2009;120:326–333.
  • Siminiak T, Wu JC, Haude M, et al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN trial. Eur J Heart Fail. 2012;14:931–938.
  • Maselli D, Guarracino F, Chiaramonti F, et al. Percutaneous mitral annuloplasty: an anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries. Circulation. 2006;114:377–380.
  • Maisano F, Taramasso M, Nickenig G, et al. Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J. 2015;37:ehv603–ehv825.
  • Kay JH, Magidson O, Meihaus JE. The surgical treatment of mitral insufficiency and combined mitral stenosis and insufficiency using the heart-lung machine. Am J Cardiol. 1962;9:300–306.
  • Nickenig G, Schueler R, Dager A, et al. Treatment of chronic functional mitral valve regurgitation with a percutaneous annuloplasty system. J Am Coll Cardiol. 2016;67:2927–2936.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.